Synergenes enters early-stage market

In December 2002, specialist private equity firm Synergenes was set up by Philippe Chaix, Claude Hennion and Denis Gavreau to invest in the biotech sector. Synergenes will invest in specific biotech sectors such as agrobiology and human biotherapy. The company aims to capitalise on the high level of research in France, as well as on the relative lack if experience in terms of management. Synergenes is planning to make between six and ten investments per year, ranging from EUR 100,000 to EUR 1m. The firm, which already has EUR 15m of funds under management, made its first investment in the Swiss company, Boost.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• France